Methylmercury: A potential environmental risk factor contributing to epileptogenesis

NeuroToxicology

Volumn 33, Issue 1, 2012, Pages 119-126

  Yuan, Yukun ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Environmental risk factors; Epileptogenesis; Methylmercury; Seizures

Indexed keywords

CALCIUM ACTIVATED POTASSIUM CHANNEL; CALCIUM CHANNEL; METHYLMERCURY; SODIUM CHANNEL;

DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; EPILEPTIC STATE; EPILEPTOGENESIS; GABAERGIC SYSTEM; GABAERGIC TRANSMISSION; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; MERCURIALISM; NERVE EXCITABILITY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEIZURE;

ANIMALS; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; ENVIRONMENTAL EXPOSURE; EPILEPSY; GAMMA-AMINOBUTYRIC ACID; HUMANS; METHYLMERCURY COMPOUNDS; RISK FACTORS;

ANIMALIA;

EID: 84855802185     PISSN: 0161813X     EISSN: 18729711     Source Type: Journal    
DOI: 10.1016/j.neuro.2011.12.014     Document Type: Review

References (173)

1. Abd-Elfattah A.S., Shamoo A.E. Regeneration of a functionally active rat brain muscarinic receptor by D-penicillamine after inhibition with methylmercury and mercuric chloride. Mol Pharmacol 1981, 20(3):492-497.
2. Albrecht J., Talbot M., Kimelberg H.K., Aschner M. The role of sulfhydryl groups and calcium in the mercuric chloride-induced inhibition of glutamate uptake in rat primary astrocyte cultures. Brain Res 1993, 607:249-254.
3. Allen J.W., Shanker G., Tan K.H., Aschner M. The consequences of methylmercury exposure on interactive functions between astrocytes and neurons. Neurotoxicology 2002, 23:755-759.
4. Arakawa O., Nakahiro M., Narahashi T. Mercury modulation of GABA-activated chloride channel and non-specific cation channels in rat dorsal root ganglion neurons. Brain Res 1991, 551:58-63.
5. Arrieta O., Palencia G., Garcia-Arenas G., Morales-Espinosa D., Hernandez-Pedro N., Sotelo J. Prolonged exposure to lead lowers the threshold of pentylenetetrazole-induced seizures in rats. Epilepsia 2005, 46:1599-1602.
6. Aschner J.L., Aschner M. Methylmercury neurotoxicity: Explore potential novel targets. Open Toxicol J 2007, 1:1-10.
7. Aschner M., Syversen T., Souza D.O., Rocha J.B., Farina M. Involvement of glutamate and reactive oxygen species in methylmercury neurotoxicity. Braz J Med Biol Res 2007, 40(3):285-291.
8. Aschner M., Yao C.P., Allen J.W., Tan K.H. Methylmercury alters glutamate transport in astrocytes. Neurochem Int 2000, 37:199-206.
9. Atchison W.D. Is chemical neurotransmission altered specifically during methylmercury-induced cerebellar dysfunction?. Trends Pharmacol Sci 2005, 26(11):549-557.
10. Atchison W.D., Hare M.F. Mechanisms of methylmercury-induced neurotoxicity. FASEB J 1994, 8:622-629.
11. Axtell C.D., Cox C., Myers G.J., Davidson P.W., Choi A.L., Cernichiari E., et al. Association between methylmercury exposure from fish consumption and child development at five and a half years of age in the Seychelles Child Development Study: an evaluation of nonlinear relationships. Environ Res 2000, 84:71-80.
12. Bakir F., Damluji S.F., Amin-Zaki L., Murtadha M., Jhalidi A., Al-Rawi N.Y., et al. Methylmercury poisoning in Iraq: an interuniversity report. Science 1973, 181:230-241.
13. Basu N., Scheuhammer A.M., Rouvinen-Watt K., Evans R.D., Trudeau V.L., Chan L.H.M. In vitro and whole animal evidence that methylmercury disrupt GABAergic systems in discrete brain regions in captive mink. Comp Biochem Physiol 2010, 151(Part C):379-385.
14. Bell I.R., Schwartz G.E., Boldwin C.M., Hardin E.E., Klimas N.G., Kline J.P., et al. Individual differences in neural sensitization and the role of context in illness from low level environmental chemical exposure. Environ Health Perspect 1997, 105(Suppl 2):457-466.
15. Bell I.R., Rossi J., Gilbert M.E., Kobal G., Morrow L.A., Newlin D.B., et al. Testing the neural sensitization and kindling hypothesis for illness from low levels of environmental chemicals. Environ Health Perspect 1997, 105(Suppl 2):539-547.
16. A receptor heterogeneity, function, and implications for epilepsy. Neurology 2007, 68:612-614.
17. Bener A., Al-Suweidi E.E.K., Bessisso M., Al-Gazali L.I., Al-Khider A. Genetics and environmental risk factors associated with febrile seizures. J Ped Newrol 2006, 4:239-243.
18. + channels: from protein complexes to function. Physiol Rev 2010, 90:1437-1459.
19. Brenner R.P., Synder R.D. Late EEG findings and clinical status after organic mercury poisoning. Arch Neurol 1980, 37:282-284.
20. Burgess D.L. Neonatal epilepsy syndromes and GEFS+: mechanistic considerations. Epilepsia 2005, 46(Suppl 10):51-58.
21. Castoldi A.F., Candura S.M., Costa P., Manzo L., Costa L.G. Interaction of mercury compounds with muscarinic receptor subtypes in the rat brain. Neurotoxicology 1996, 17:735-741.
22. Castoldi A., Coccini T., Ceccatelli S., Manzo L. Neurotoxicity and molecular effects of methylmercury. Brain Res Bull 2001, 55:197-203.
23. Catteral W.A., Kalume F., Oakley J.C. NaV1.1 channels and epilepsy. J Physiol 2010, 588:1849-1859.
24. Chang L.W., Hartmann H.A. Ultrastructural studies of the nervous system after mercury intoxication. I. Pathological changes in the nerve cell bodies. Acta Neuropathol 1972, 20:122-138.
25. Chang L.W. Mercury. Experimental and clinical neurotoxicology 1980, 508-526. The Williams and Wilkins Co, New York. P.S. Spencer, H.H. Schaumburg (Eds.).
26. Clarkson T.W., Magos l., Myers G. The toxicology of mercury-current exposure and clinical manifestations. N Engl J Med 2003, 349:1731-1737.
27. Clarkson T.W., Magos L. The toxicology of mercury and its chemical compounds. Crit Rev Toxicol 2006, 36:609-662.
28. Coccini T., Randine G., Candura S.M., Nappi R.E., Prockop L.D., Manzo L. Low-level exposure to methylmercury modifies muscarinic cholinergic receptor binding characteristics in rat brain and lymphocytes: physiologic implications and new opportunities in biologic monitoring. Environ Health Perspect 2000, 108:29-33.
29. Cooper E.C., Jan L.Y. M-channels: neurological diseases, neuromodulation, and drug development. Arch Neurol 2003, 60:496-500.
30. Cordier S., Garel M., Mandereau L., Morcel H., Doineau P., Gosme-Seguret S., et al. Neurodevelopmental investigations among methylmercury-exposed children in French Guiana. Environ Res 2002, 89:1-11.
31. Counter S.A., Buchanan L.H. Mercury exposure in children: a review. Toxicol Appl Pharmacol 2004, 198:209-230.
32. Crump K.S., Kjellström T., Shipp A.M., Silvers A., Stewart A. Influence of prenatal mercury exposure upon scholastic and psychological test performance: benchmark analysis of a New Zealand cohort. Risk Anal 1998, 18:701-713.
33. D'Ambrosio R., Perucca E. Epilepsy after head injury. Curr Opin Neurol 2004, 17:731-735.
34. Dasari S., Yuan Y. Methylmercury exposure in vivo induces a long-lasting epileptiform activity in layer II/III neurons in cortical slices of rat. Toxicol Lett 2010, 193:138-143.
35. Davidson P.W., Myers G.J., Cox C., Axtell C., Shamlaye C., Sloane-Reeves J., et al. Effects of prenatal and postnatal methylmercury exposure from fish consumption on neurodevelopment: outcomes at 66 months of age in the Seychelles Child Development Study. JAMA 1998, 280:701-707.
36. Davidson P.W., Palumbo D., Myers G.J., Cox C., Shamlaye C.F., Sloane-Reeves J., et al. Neurodevelopmental outcomes of Seychellois children from the pilot cohort at 108 months following prenatal exposure to methylmercury from a maternal fish diet. Environ Res 2000, 84:1-11.
37. Davidson P.W., Myers G.J., Cox C., Wilding G.E., Shamlaye C.F., Huang L.S., et al. Methylmercury and neurodevelopment: longitudinal analysis of the Seychelles child development cohort. Neurotoxicol Teratol 2006, 28:529-535.
38. Davis L.E., Kornfeld M., Mooney H.S., Fiedler K.J., Haaland K.Y., Orrison W.W., et al. Methylmercury poisoning: long-term clinical, radiological, toxicological, and pathological studies of an affected family. Ann Neurol 1994, 35:680-688.
39. Denays R., Kumba C., Lison D., De Bels D. First epileptic seizures induced by occupational nickel poisoning. Epilepsia 2005, 46:961-962.
40. Doherty S.P., Grabowski J., Hoffman C., Ng S.P., Zelikoff J.T. Early life insult from cigarette smoke may be predictive of chronic diseases later in life. Biomarkers 2009, 1(Suppl):97-101.
41. Eggermann E., Feldmeyer D. Cholinergic filtering in the recurrent excitatory microcircuit of cortical layer 4. Proc Natl Acad Sci U S A 2009, 106:11753-11758.
42. Eldefrawi M.E., Mansor N.A., Eldefrawi A.T. Interactions of acetylcholine receptors with organic mercury compounds. Adv Exp Med Biol 1977, 84:449-463.
43. Escalantie-Membrillo C., Paz C. Development of an experimental model of epilepsy in rats exposed to ozone. Toxicol Lett 1997, 93:103-107.
44. Eto K., Yasutake A., Kuwana T., Korogi Y., Akima M., Shimozeki T., Tokunaga H., Kaneko Y. Methylmercury poisoning in common marmosets-a study of selective vulnerability within the cerebral cortex. Toxicol Pathol 2001, 29:565-573.
45. Eto K., Yasutake A., Nakano A., Akagi H., Tokunaga H., Kojima T. Reappraisal of the historic 1959 cat experiment in Minamata by the Chisso factory. Tohoku J Exp Med 2001, 194:197-203.
46. Eto K., Yasutake A., Korogi Y., Akima M., Shimozeki T., Tokunaga H., Juwana T., Kaneko Y. Methylmercuty poisoning in common marmosets-MRI findings and peripheral nerve leisions. Toxicol pathol 2002, 30:723-734.
47. Faber E.S., Sah P. Functions of SK channels in central neurons. Clin Exp Pharmacol Physiol 2007, 34:1077-1083.
48. A receptor modulates the benzodiazepine binding site inprimary cultures of mouse cerebellar granule cells. Neuropharmacology 2001, 41:819-833.
49. Fountain S.B., Rowan J.D. Effects of sequential exposure to multiple concentrations of methylmercury in the rat hippocampal slice. Ecotoxicol Environ Safety 2000, 47:130-136.
50. Fox D.A., Opannashuk L., Zharkovsky A., Weiss B. Gene-chemical interactions in the developing mammalian nervous system: effects on proliferation, neurogenesis and differentiation. Neurotoxicology 2010, 31:589-597.
51. Fredriksson A., Dencker L., Archer T., Danielsson B.R.G. Prenatal coexposure to metallic mercury vapour and methylmercury produce interactive behavioural changers in adult rats. Neurotoxicol Teratol 1996, 18:129-134.
52. Frey L.C. Epidemiology of posttraumatic epilepsy: a critical review. Epilepsia 2003, 44(Suppl 10):11-17.
53. Gilbert M.E. Does the kindling model of epilepsy contribute to our understanding of multiple chemical sensitivity. Ann N Y Acad Sci 2001, 933:68-91.
54. Gibertson M. Male cerebral palsy hospitalization as a potential indicator of neurological effects of methylmercury exposure in Great Lakes communities. Environ Res 2004, 75:375-384.
55. Gibertson M. Index of congenital Minamata disease in Canadian areas of concern in the Great Lakes: an eco-social epidemiological approach. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 2009, 27:246-275.
56. Gold P.E. Acetylcholine modulation of neural systems involved in learning and memory. Neurobiol Learn Mem 2003, 80:194-210.
57. Grandjean P., Weihe P., White R.F., Debes F., Araki S., Yokoyama K., et al. Cognitive deficit in 7-year-old children with prenatal exposure to methylmercury. Neurotoxicol Teratol 1997, 19:417-428.
58. Grandjean P., Weihe P., White R.F., Debes F. Cognitive performance of children prenatally exposed to safe levels of methylmercury. Environ Res 1998, 77:165-172.
59. Grandjean P., White R.F., Nielsen A., Cleary D., de Oliveira Santos E.C. Methylmercury neurotoxicity in Amazonian children downstream from gold mining. Environ Health Perspect 1999, 107:587-591.
60. Grandjean P., Satoh H., Murata K., Eto K. Adverse effects of methylmercury: environmental health research implications. Environ Health Perspect 2010, 118:1137-1145.
61. Grandjean P., Herz K.T. Methylmercury and brain development: imprecision and underestimation of developmental neurotoxicity in humans. Mt Sinai J Med 2011, 78:107-118.
62. Graves T.D. Ion channel and epilepsy. Q J Med 2006, 99:201-217.
63. Gulledge A.T., Stuart G.J. Cholinergic inhibition of neocortical pyramidal neurons. J Neurosci 2005, 25:10308-10320.
64. Gulledge A.T., Bucci D.J., Zhang S.S., Matsui M., Yeh H.H. M1 receptors mediate cholinergic modulation of excitability in neocortical pyramidal neurons. J Neurosci 2009, 29:9888-9902.
65. Gururaj A.K., Sztriha L., Bener A., Dawodu A., Eapen V. Epilepsy in children with cerebral palsy. Seizure 2003, 12:110-114.
66. Haj-Dahmane S., Andrade R. Muscarinic activation of a voltage-dependent cation nonselective current in rat association cortex. J Neurosci 1996, 16:3848-3861.
67. Harada Y. Congenital (or fetal) Minamata Bay disease. In: Study Group of Minamata Disease, editors. Minamata disease. Kumamoto University, Japan; 1968. p. 73-91.
68. Harada Y. Congenital Minamata disease. Minamata disease: methylmercury poisoning in Minamata and Niigata, Japan 1979, 209-269. Elsevier, New York. T. Tsubaki, K. Irukayama (Eds.).
69. Harada M. Minamata disease: methylmercury poisoning in Japan caused by environmental pollution. Crit Rev Toxicol 1995, 25:1-24.
70. Hasselmo M.E. The role of acetylcholine in learning and memory. Curr Opin Neurobiol 2006, 16:710-715.
71. Hauser W.A., Annegers J.F., Kurland L.T. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia 1993, 34:453-468.
72. Hauser W.A. The prevalence and incidence of convulsive disorders in children. Epilepsia 1994, 35:S1-S6.
73. A receptor currents in rat cerebellar granule cells and cerebral cortical neurons in culture. J Pharmacol Exp Ther 2008, 324:517-528.
74. Hernandez E.H., Discalzi G., Dassi P., Jarre L., Pira E. Manganese intoxication: the cause of an inexplicable epileptic syndrome in a 3 year old child. Neurotoxicology 2003, 24:633-639.
75. Hirose S. A new paradigm of channelopathy in epilepsy syndromes: intracellular trafficking abnormality of channel molecules. Epilepsy Res 2006, 70S:S206-S217.
76. Hogberg H.T., Kinsner-Ovaskainen A., Coecke S., Hartung T., Bal-Price A.K. mRNA expression is a relevant tool to identify developmental neurotoxicants using an in vitro approach. Toxicol Sci 2010, 113:95-115.
77. Hunter D., Russell D.S. Focal cerebral and cerebellar atrophy in a human subject due to organic mercury compounds. Neurol Neurosurg Psychiat 1954, 17:235-241.
78. Jensen F.E. Neonatal seizures: an update on mechanisms and management. Clin Perinatol 2009, 36:881-900. vii.
79. Juárez B.I., Martínez M.L., Montante M., Dufour L., García E., Jiménez-Capdeville M.E. Methylmercury increases glutamate extracellular levels in frontal cortex of awake rats. Neurotoxicol Teratol 2002, 24:767-771.
80. Kjeldsen M.J., Kyvik K.O., Friis M.L., Christensen K. Genetic and environmental factors in febrile seizures: a Danish population-based twin study. Epilepsy Res 2002, 51:167-177.
81. A receptor complex differentially in rat cortical and cerebellar membranes in vitro. Neurochem Res 1995, 20:659-662.
82. Krishnamoorthy M.S., Parthiban N., Muthu P., Paul V., Balagopal G., Kumaravel T.S. Effect of acute pretreatment of lead on picrotoxin-induced convulsions in rats. J Appl Toxicol 1993, 13:155-159.
83. Kurland L.T., Faro S.N., Siedler H. Minamata Disease. The outbreak of a neurologic disorder in Minamata, Japan, and its relationship to the ingestion of seafood contaminated by mercuric compounds. World Neurol 1960, 1:370-395.
84. Kwong K.L., Wong S.N., So K.T. Epilepsy in children with cerebral palsy. Pediatr Neurol 1998, 19:31-36.
85. Landrigan P.J., Sonawane B., Butler R.N., Trasande L.M., Callan R., Droller D. Early environmental origins of neurodegenerative disease in later life. Environ Health Perspect 2005, 113:1230-1233.
86. Lerche H., Jurkat-Rott K., Lehmann-Horn F. Ion channel and epilepsy. Amer J Med Jenet 2001, 106:146-159.
87. Leonhardt R., Haas H., Büsselberg D. Methyl mercury reduces voltage-activated currents of rat dorsal root ganglion neurons. Naunyn-Schmiedeberg's Arch Pharmacol 1996, 354:532-538.
88. 2+ dysregulation and neuronal death in rat cerebellar granule cells through an M3 muscarinic receptor-linked pathway. Toxicol Sci 2004, 80:60-68.
89. Limke T.L., Heidemann S.R., Atchison W.D. Disruption of intraneuronal divalent cation regulation by methylmercury: are specific targets involved in altered neuronal development and cytotoxicity in methylmercury poisoning?. Neurotoxicology 2004, 25:741-760.
90. Lowenstein D.H. Epilepsy after head injury: an overview. Epilepsia 2009, 50(Suppl 2):4-9.
91. A receptor subunits associated with genetic epilepsies. J Physiol (Lond) 2010, 588:1861-1869.
92. Mantegazza M., Rusconi R., Scalmani P., Avanzini G., Franceschetti S. Epileptogenic ion channel mutations: from bedside to bench and, hopefully, back again. Epilepsy Res 2010, 92:1-29.
93. Marsh D.O., Clarkson T.W., Cox C., Myers G.J., Amin-Zaki L., Al-Tikriti S. Fetal methylmercury poisoning. Relationship between concentration in single strands of maternal hair and child effects. Arch Neurol 1987, 44:1017-1022.
94. Marsh D.O., Clarkson T.W., Myers G.J., Davidson P.W., Cox C., Cernichiari E., et al. The Seychelles study of fetal methylmercury exposure and child development: introduction. Neurotoxicology 1995, 16:583-596.
95. Mathai K.V., Dunn D.P., Kurland L.T., Reeder F.A. Covulsive disorders in the Mariana Islands. Epilepsia 1968, 9:77-85.
96. McDonough J.H., Shin T. Neuropharmacological mechanisms of nerve agent-induced seizure and neuropathology 1997, 21:559-579.
97. McKeown-Eyssen G.E., Ruedy J., Neims A. Methyl mercury exposure in northern Quebec. II. Neurologic findings in children. Am J Epidemiol 1983, 118:470-479.
98. Menashi M., Ornoy A., Yanai J. Transplacental effects of methylmercury chloride in mice with specific emphasis on the audiogenic seizure response. Dev Neurosci 1982, 5:216-221.
99. Merigan W.H., Maurissen J.P.J., Weiss B., Eskin T., Lapham L.W. Neurotoxic actions of methylmercury on the primate visual system. Neurobehav Toxicol Teratol 1983, 5:649-658.
100. Montandon G., Horner R.L., Kinkead R., Bairam A. Caffeine in the neonatal period induces long-lasting changes in sleep and breathing in adult rats. J Physiol (Lond) 2009, 587:5493-5507.
101. Myers G.J., Davidson P.W., Cox C., Shamlaye C.F., Tanner M.A., Marsh D.O., et al. Summary of the Seychelles child development study on the relationship of fetal methylmercury exposure to neurodevelopment. Neurotoxicology 1995, 16:711-716.
102. Myers G.J., Davidson P.W., Shamlaye C.F., Axtell C.D., Cernichiari E., Choisy O., et al. Effects of prenatal methylmercury exposure from a high fish diet on developmental milestones in the Seychelles Child Development Study. Neurotoxicology 1997, 18:819-829.
103. Myers G.J., Davidson P.W., Cox C., Shamlaye C.F., Palumbo D., Cernichiari E., et al. Prenatal methylmercury exposure from ocean fish consumption in the Seychelles child development study. Lancet 2003, 361:1686-1692.
104. Myers G.J., Thurston S.W., Pearson A.T., Davidson P.W., Cox C., Shamlaye C.F., et al. Postnatal exposure to methyl mercury from fish consumption: a review and new data from the Seychelles Child Development Study. Neurotoxicology 2009, 30:338-349.
105. Myhrer T. Neuronal structures involved in the induction and propagation of seizures caused by nerve agents: implications for medical treatment. Toxicology 2007, 239:1-14.
106. Nagashima K. A review of experimental methylmercury toxicity in rats: neuropathology and evidence for apoptosis. Toxicologic Pathol 1997, 25:624-631.
107. Nagashima K., Fujii Y., Tsukamoto T., Nukuzuma S., Satoh M., Fujita M., Fujioka Y., Akagi H. Apoptotic process of cerebellar degeneration in experimental methylmercury intoxication of rats. Acta Neuropathol 1996, 91:72-77.
108. Nakayama J. Progress in searching for the febrile seizure susceptibility genes. Brain Dev Brain Dev 2009, 31:359-365.
109. Ng S.P., Conklin D.J., Bhatnagar A., Bolanowski D.D., Lyon J., Zelikoff T. Prenatal exposure to cigarette smoke induces diet- and sex-dependent dyslipidemia and weight gain in adult murine offspring. Environ. Health Perspect 2009, 117:1042-1048.
110. Nierenberg D.W., Nordgren R.E., Chang M.B., Siegler R.W., Blayney M.B., Hochberg F., et al. Delayed cerebellar disease and death after accidental exposure to dimethylmercury. N Engl J Med 1998, 338:1672-1676.
111. Nishimura T., Schwarzer C., Furtinger A., Lmai H., Kato N., Sperk G. Changes in the GABA-ergic system induced by trimethyltin application in the rat. Mol Brain Res 2001, 97:1-6.
112. Ogiwara I., Miyamoto H., Morita N., Atapour N., Mazaki E., Inoue I., Takeuchi T., Itohara S., Yanagawa Y., Obata K., Furuichi T., Hensch T.K., Yamakawa K. Nav1.1 localizes to axons of parvalbumin-positive inhibitory interneurons: a circuit basis for epileptic seizures in mice carrying an Scn1a gene mutation. J Neurosci 2007, 27:5903-5914.
113. O'Kusky J.R. Synapse elimination in the developing visual cortex: a morphometric analysis in normal and dark-reared cats. Brain Res 1985, 354:81-91.
114. O'Kusky J.R., McGeer E.G. Methylmercury poisoning of the developing nervous system in the rat; decreased activity of glutamic acid decarboxylase in cerebral cortex and neostriatum. Develop Brain Res 1985, 21:299-306.
115. O'Kusky J.R., Radke J.M., Vincent S.R. Methylmercury-induced movement and postural disorders in developing rat: loss of somatostatin-immunoreactive interneurons in the striatum. Develop Brain Res 1988, 40:11-23.
116. Olafsson E., Ludvigsson P., Gudmundsson G., Hesdorffer D., Kjartansson O., Hauser W.A. Incidence of unprovoked seizures and epilepsy in Iceland and assessment of the epilepsy syndrome classification: a prospective study. Lancet Neurol 2005, 4:627-634.
117. Parent J.M., Murphy G.G. Mechanisms and functional significance of aberrant seizure-induced hippocampal neurogenesis. Epilepsia 2008, 49(Suppl 5):19-25.
118. Peng S., Hajela R.K., Atchison W.D. Effects of methylmercury on human neuronal L-type calcium channels transiently expressed in human embryonic kidney cells (HEK-293). J Pharmacol Exp Ther 2002, 302:424-432.
119. 2+ channels transiently expressed in human embryonic kidney 293 cells. Mol Pharmacol 2002, 62:1418-1430.
120. Prince D.A., Parada I., Scalise K., Graber K., Jin X., Shen F. Epilepsy following cortical injury: cellular and molecular mechanisms as targets for potential prophylaxis. Epilepsia 2009, 50(Suppl 2):30-40.
121. Quandt F.N., Kato E., Narahashi T. Effects of methylmercury on electrical responses of neuroblastoma cells. NeuroToxicology 1982, 3:205-220.
122. Rasmussen E.B., Newland M.C. Developmental exposure to methylmercury alters behavioral sensitivity to d-amphetamine and pentobarbital in adult rats. Neurtoxicl Teratol 2001, 23:45-55.
123. Rice D.C., Gilbert S.G. Early chronic low-level methylmercury poisoning in monkeys impairs spatial vision. Science 1982, 216:759-761.
124. Roda E., Coccini T., Acerbi D., Castoldi A., Bernocchi G., Manzo L. Cerebellum cholinergic muscarinic receptor (subtype-2 and -3) and cytoarchitecture after developmental exposure to methylmercury: an immunohistochemical study in rat. J Chem Neuroanat 2008, 35:285-294.
125. Ronen G.M., Penney S., Andrews W. The epidemiology of clinical neonatal seizures in Newfoundland: a population-based study. J Pediatr 1999, 134:71-75.
126. Rustam H., Hamdi T. Methyl mercury poisoning in Iraq: a neurological study. Brain 1974, 97:499-510.
127. 2+ channel blockers against methyl mercury toxicity. Pharmacol Toxicol 1996, 78:193-199.
128. Scharfman H.E., McCloskey D.P. Postnatal neurogenesis as a therapeutic target in temporal lobe epilepsy. Epilepsy Res 2009, 85(Aug 2-3):150-161.
129. Shafer T.J. Methylmercury effects on ion channels and electrical activity in neurons: future directions. Cell Mol Biol (Noisy-le-grand) 2000, 46:855-864.
130. ++ channels in nerve-growth factor-differentiated pheochromocytoma (PC12) cells. J Pharmacol Exp Ther 1991, 258:149-157.
131. 2+-dependent potentials at neuromuscular junctions of the mouse. Brain Res 1992, 595:215-219.
132. Shafer T.J., Meacham C.A., Barone S.J. Effects of prolonged exposure to nanomolar concentrations of methylmercury on voltage-sensitive sodium and calcium currents in PC12 cells. Brain Res Dev Brain Res 2002, 136:151-164.
133. Shamoo A.E., Maclennan D.H., Elderfrawi M.E. Differential effects of mercurial compounds on excitable tissues. Chem Biol Interact 1976, 12:41-52.
134. Shaw C.M., Mottet N.K., Body R.L., Luschei E.S. Variability of neuropathologic lesions in experimental methylmercurial encephalopathy in primates. Am J Pathol 1975, 80:451-470.
135. Shrivastav B.B., Brodwick B.S., Narahashi T. Methylmercury: effects on electrical properties of squid axon membranes. Life Sci 1976, 18:1077-1081.
136. Singh G., Prabhakar S. The association between central nervous system (CNS) infections and epilepsy: epidemiological approaches and microbiological and epileptological perspectives. Epilepsia 2008, 49(Suppl 6):2-7.
137. Sirois J.E., Atchison W.D. Methylmercury affects multiple subtypes of calcium channels in rat cerebellar granule cells. Toxical Appl Pharmcol 2000, 167:1-11.
138. Šlamberová R., Bernášková K., Matějovská I., Schutová B. Does prenatal methamphetamine exposure affect seizure susceptibility in adult rats with acute administration of the same drugs. Epilepsy Res 2008, 78:33-39.
139. Solberg Y., Belkin M. The role of excitotoxicity in organophosphorous nerve agents central poisoning. Trends Pharmacol Sci 1997, 18:183-185.
140. Sorg B.A., Prasad B.M. Potential role of stree and sensitization in the development and expression of multiple chemical sensitivity. Environ Health Perpect 1997, 105(Suppl 2):467-471.
141. Stanhope J.M., Brody J.A., Brink E. Convulsions among the Chamorro people of Guam, Mariana islands. I. Seizure disorders. Am J Epidemiol 1972, 95:292-298.
142. Stewardt I. Environmental risk factors for temporal lobe epilepsy - Is prenatal exposure to the marine algal neurotoxin domoic acid a potentially preventable cause. Med Hypoth 2010, 74:466-481.
143. Stocker M. Ca(2+)-activated K+ channels: molecular determinants and function of the SK family. Nat Rev Neurosci 2004, 5:758-770.
144. Su M-Q., Okita G.T. Behavioral effects on the progeny of mice treated with methylmercury. Toxicol Appl Pharmacol 1976, 38:195-205.
145. Suzuki K., Nakai K., Sugawara T., Nakamura T., Ohba T., Shimada M., et al. Neurobehavioral effects of prenatal exposure to methylmercury and PCBs, and seafood intake: neonatal behavioral assessment scale results of Tohoku study of child development. Environ Res 2010, 110:699-704.
146. Synder R.D. Congenital mercury poisoning. N Engl J Med 1971, 284:1014-1016.
147. Syversen T.L.M., Totland G., Flood P.R. Early morphological changes in rat cerebellum caused by a single dose of methylmercury. Arch Toxicol 1981, 47:101-111.
148. Szász A., Barna B., Szupera Z., De Visscher G., Galbács Z., Kirsch-Volders M., et al. Chronic low-dose maternal exposure to methylmercury enhances epileptogenicity in developing rats. Int J Dev Neurosci 1999, 17:733-742.
149. Szász A., Barna B., Szupera Z., De Visscher G., Galbács Z., Kirsch-Volders M., et al. Effects of continuous low-dose exposure to organic and inorganic mercury during development on epileptogenicity in rats. NeuroToxicology 2002, 23:197-206.
150. Takeuchi T., Kambara T., Morikawa N., Matsumoto H., Shiraishi Y., Ito H. Pathologic observations of the Minamata disease. Acta Pathol J 1959, 9:769-783.
151. Takeuchi T., Morikawa N., Matsumoto H., Shiraishi Y. A patholgical study of Minamata Disearse in Japan. Acta Neuropathol 1962, 2:40-57.
152. Tiedeken J.A., Ramsdell J.S. Embryonic exposure to domoic acid increases the susceptibility of zebrafîsh larvae to the chemical convulsant pentylenetetraz. Environ Health Perspect 2007, 115:1547-1552.
153. Todorova M.T., Burwell T.J., Seyfried T.N. Environmental risk factors for multifactorial epilepsy in EL mice. Epilepsia 1999, 40:1697-1707.
154. Todorova M.T., Mantis J.G., Le M., Kim C.Y., Seyfried T.N. Genetic and environmental interactions determine seizure susceptibility in epileptic EL mice. Gens Brain Behav 2006, 5:519-527.
155. Tokuomi H., Okajima T. Minamata disease. World Neurol 1961, 2:536-545.
156. Tsuboi T. Prevalence and incidence of epilepsy in Tokyo. Epilepsia 1988, 29:103-110.
157. Tsuboi T., Okada S. Seasonal variation of febrile convulsion in Japan. Acta Neurol Scand 1984, 69:285-292.
158. Vathy I. Prenatal morphine exposure induces age- and sex-dependent changes in seizure susceptibility. Prog Neuro-psychopharmacol Bio Psychiat 2001, 25:1203-1226.
159. Vergara C., Latorre R., Marrion N.V., Adelman J.P. Calcium-activated potassium channels. Curr Opin Neurobiol 1998, 8:321-329.
160. Vestergaard M., Christensen J. Register-based studies on febrile seizures in Denmark. Brain Dev 2009, 51:372-377.
161. Világi I., Dóczi J., Banczerowski-Pelyhe I. Altered electrophysiological characteristics of developing rat cortical neurones after chronic methylmercury chloride treatment. Int J Dev Neurosci 2000, 18:493-499.
162. Von Burg R., Northington F.K., Shamoo A. Methylmercury inhibition of muscarinic receptor. Toxicol Appl Pharmacol 1980, 53:285-292.
163. Wagner G.C., Reuhl K.R., Ming X., Halladay A.K. Behavioral and neurochemical sensitization to amphetamine following early postnatal administration of methylmercury (MeHg). Neurotoxicology 2007, 28:59-66.
164. Wakabayshi K., Kakita A., Sakamoto M., Su M., Iwanaga K., Ikuta F. Variability of brain lesions in rats administered methylmercury at various postnatal development phases. Brain Res 1995, 705:267-272.
165. Weiss B. Vulnerability of children and the developing brain to neurotoxic hazards. Environ Health Perspect 2000, 108(Suppl 3):375-381.
166. Weiss B., Clarkson T.W., Simon W. Silent latency periods in methylmercury poisoning and in neurodegenerative disease. Environ Health Perspect 2002, 110:851-854.
167. Yu F.H., Mantegazza M., Westenbroek R.E., Robbins C.A., Kalume F., Burton K.A., Spain W.J., McKnight G.S., Scheuer T., Catterall W.A. Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy. Nat Neurosci 2006, 9:142-1149.
168. Yuan Y., Atchison W.D. Disruption by methylmercury of membrane excitability and synaptic transmission in hippocampal slices of the rat. Toxicol Appl Pharmacol 1993, 120:203-215.
169. Yuan Y., Atchison W.D. Methylmercury act at multiple sites to block hippocampal synaptic transmission. J Pharmacol Exp Ther 1995, 275:1308-1316.
170. Yuan Y., Atchison W.D. Action of methylmercury on GABA(A) receptor-mediated inhibitory synaptic transmission is primarily responsible for its early stimulatory effects on hippocampal CA1 excitatory synaptic transmission. J Pharmacol Exp Ther 1997, 282:64-73.
171. A receptor-mediated spontaneous IPSCs in Purkinje and granule cells of rat cerebellar slices. J Physiol (Lond) 2003, 550:191-204.
172. Yuan Y., Otero-Montañez J.K.L., Yao A., Herden C.J., Sirois J.E., Atchison W.D. Inwardly rectifying and voltage-gated outward potassium channels exhibit low sensitivity to methylmercury. Neurotoxicology 2005, 26:439-454.
173. 2+ increases spontaneous synaptic current frequency in rat cerebellar slices. Mol Pharmacol 2007, 71:1109-1121.